Returning to Boston, Massachusetts, this July for a 4th year, the mRNA-Based Therapeutics Summit’s 2024 agenda cements its position as the industry’s most comprehensive end-to-end mRNA meeting.
Showcasing the mRNA field’s latest advancements, hear from 65+ world-class speakers (including the likes of the FDA, EMA, CureVac, BioNTech, Sanofi and Moderna) across three days jam-packed with content.
Join over 400 of your mRNA peers for industry-led sessions spanning proof-of-concept studies, platform development, clinical updates, manufacturing strategies and regulatory insights across 4 tracks of content, catering to Discovery, Translation, Clinical Development and Chemistry, Manufacturing & Controls.
Gain exclusive strategic and scientific insights shared by 20+ C-level executives from mRNA biotechs, key thought leaders from large pharma, and regulatory experts, with an agenda focused on helping you ensure the durability, tolerability and targeted delivery of your mRNA-based therapeutics and vaccines, across all disease indications.
Agenda highlights include:
- Unlock the next frontiers of mRNA-based vaccine and therapeutic strategies to stay ahead of the curve in the brand-new CEOs’ Panel Discussion with CureVac, Arcturus Therapeutics, Sail Biomedicines, Innovac Therapeutics, Radar Therapeutics, Gritstone Bio and Replicate Bioscience
- Uncover the mRNA regulatory and industry landscapes for cancer, rare, and infectious diseases to harmonize expectations with the FDA, EMA, GSK, Moderna and Cartesian Therapeutics
- Dive into the latest clinical results from Moderna’s mRNA trials for melanoma, rare metabolic disorders and norovirus, paving the way towards the next successful approval for patients
To maximize your experience, join the Next Generation mRNA Delivery or Regulatory Affairs Strategy focus days, exchange business cards during Speed Networking, quiz your peers in the Scientific Poster Session and have your voice heard during the Roundtable Discussions.